These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8093907)

  • 1. Potent quinoxaline-spaced phosphono alpha-amino acids of the AP-6 type as competitive NMDA antagonists: synthesis and biological evaluation.
    Baudy RB; Greenblatt LP; Jirkovsky IL; Conklin M; Russo RJ; Bramlett DR; Emrey TA; Simmonds JT; Kowal DM; Stein RP
    J Med Chem; 1993 Feb; 36(3):331-42. PubMed ID: 8093907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 type.
    Baudy RB; Fletcher H; Yardley JP; Zaleska MM; Bramlett DR; Tasse RP; Kowal DM; Katz AH; Moyer JA; Abou-Gharbia M
    J Med Chem; 2001 May; 44(10):1516-29. PubMed ID: 11334562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacology of a series of 3- and 4-(phosphonoalkyl)pyridine- and -piperidine-2-carboxylic acids. Potent N-methyl-D-aspartate receptor antagonists.
    Ornstein PL; Schaus JM; Chambers JW; Huser DL; Leander JD; Wong DT; Paschal JW; Jones ND; Deeter JB
    J Med Chem; 1989 Apr; 32(4):827-33. PubMed ID: 2539478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of cyclopropyl analogues of 2-amino-5-phosphonopentanoic acid.
    Dappen MS; Pellicciari R; Natalini B; Monahan JB; Chiorri C; Cordi AA
    J Med Chem; 1991 Jan; 34(1):161-8. PubMed ID: 1671413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent, orally active, competitive N-methyl-D-aspartate (NMDA) receptor antagonists are substrates for a neutral amino acid uptake system in Chinese hamster ovary cells.
    Li JH; Bigge CF; Williamson RM; Borosky SA; Vartanian MG; Ortwine DF
    J Med Chem; 1995 May; 38(11):1955-65. PubMed ID: 7783127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic iron complexes derived from the nitric oxide donor nitroprusside: competitive N-methyl-D-aspartate receptor antagonists with nanomolar affinity.
    Neijt H; Koller M; Urwyler S
    Biochem Pharmacol; 2001 Feb; 61(3):343-9. PubMed ID: 11172739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of N-phosphonoalkyl-, N-phosphonoalkenyl-, and N-(phosphonoalkyl)phenyl-spaced alpha-amino acids as competitive N-methyl-D-aspartic acid antagonists.
    Bigge CF; Johnson G; Ortwine DF; Drummond JT; Retz DM; Brahce LJ; Coughenour LL; Marcoux FW; Probert AW
    J Med Chem; 1992 Apr; 35(8):1371-84. PubMed ID: 1533423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action.
    Ornstein PL; Schoepp DD; Arnold MB; Leander JD; Lodge D; Paschal JW; Elzey T
    J Med Chem; 1991 Jan; 34(1):90-7. PubMed ID: 1825117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives.
    Fray MJ; Bull DJ; Carr CL; Gautier EC; Mowbray CE; Stobie A
    J Med Chem; 2001 Jun; 44(12):1951-62. PubMed ID: 11384240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl-D-aspartate receptor binding is altered and seizure potential reduced in pregnant rats.
    Standley CA
    Brain Res; 1999 Oct; 844(1-2):10-9. PubMed ID: 10536256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-D-aspartate (NMDA) receptor antagonist, in vitro and in vivo.
    Vazquez ML; Garland DJ; Sun ET; Cler JA; Mick SJ; Hood WF; Monahan JB; Iyengar S; Rao TS
    Neurosci Lett; 1992 Feb; 135(2):149-52. PubMed ID: 1352628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for multiple forms of an N-methyl-D-aspartate recognition domain in rat brain using membrane binding techniques.
    Zuo P; Ogita K; Suzuki T; Han D; Yoneda Y
    J Neurochem; 1993 Nov; 61(5):1865-73. PubMed ID: 7901335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex allosteric modulation of the binding of the NMDA receptor antagonist [3H]CGP39653.
    Oblin A; Schoemaker H
    Eur J Pharmacol; 1994 Jan; 266(1):103-6. PubMed ID: 7907987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Support for radiolabeling of a glycine recognition domain on the N-methyl-D-aspartate receptor ionophore complex by 5,7-[3H]dichlorokynurenate in rat brain.
    Yoneda Y; Suzuki T; Ogita K; Han D
    J Neurochem; 1993 Feb; 60(2):634-45. PubMed ID: 8419541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.